Extraordinary Shareholders' Meeting Of Cytos Biotechnology Ltd: Shareholders Approve All Resolutions
Published: Dec 30, 2013
ZURICH, November 4, 2013 /PRNewswire/ --
Cytos Biotechnology Ltd (SIX:CYTN) today announced that its shareholders have approved all resolutions at the Extraordinary Shareholders' Meeting the announced capital increase in particular.
The Extraordinary Shareholders' Meeting of Cytos Biotechnology Ltd took place at the company's headquarters in Schlieren (Zurich), Switzerland. It was attended by 28 shareholders. 12,673,384 shares or 56.55% of a total of 22,411,431 shares were represented.
Help employers find you! Check out all the jobs and post your resume.